A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Massachusetts General Hospital
Merck Sharp & Dohme LLC
Pancreatic Cancer Action Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Ghent
University of Colorado, Denver
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Washington University School of Medicine
Brown University
Ohio State University Comprehensive Cancer Center